BD Ventures

Contact: Edward J Ludwig, Chairman, President    Email this Investor

• Biotechnology
• Business and consumer products
• Computer hardware
• Financial services
• Healthcare
• IT services
• Industrial and energy products
• Media and entertainment
• Medical Equipment
• Networking
• Retailing and distribution
• Semiconductors
• Software
• Telecommunications
• Real estate

• Seed
• 1st Round
• 2nd Round
• 3rd Round
• 4th Round and later
• Pre-IPO
• Mezzanine
• Buyout/acquisition

• Private Company (backed by venture capital firms)
• Private Company (not backed by venture capital firms)
• Public Company

BD (Becton, Dickinson and Company) is a global medical technology company that is focused on improving drug therapy, enhancing the diagnosis of infectious diseases and advancing drug discovery. BD manufactures and sells medical supplies, devices, laboratory instruments, antibodies, reagents and diagnostic products through its three segments: BD Medical, BD Diagnostics and BD Biosciences. It serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Email this Investor